Diabetes

Please Note: The technologies listed here are not available to the public at this time. These technologies are in the early stages of research and require further development before they are ready for the marketplace. The VA is currently in the process of identifying potential companies who may be interested in licensing and/or further developing the technology through Cooperative Research and Development Agreements (CRADA). Through cooperative research initiatives such as these, it is our hope and goal that commercial products will be fully developed and made available to benefit veterans and others.


Date Posted

Reference No.

Patent No.

Title

08/11/2008

08-002

Automated Diabetes Control in the ICU

05/18/2006

05-082

5,834,032

Composition and Methods for Treating Diabetes

03/12/2007

04-075

Treatment of Type 2 Diabetes with a LoBAG (Low Biologically Available Glucose) Diet

07/07/2004

02-124

Isolation and Characterization of Human Marrow-Isolated Adult Multipotent Inducible (MIAMI) Cells

11/24/2003

02-106

Use of Clonal Human hNT2 Neuronal Cell Lines as ‘Cellular Minipumps’ to Treat Neurodegenerative Disorders and the Consequences of Brain and Spinal Cord Injuries

07/26/2004

02-030

Engineered Stem Cells Delivered Directly into Digestive Organs for Drug Delivery, Gene Therapy, Cell Replacement, Research and Diagnostic Applications

04/12/2002

00-033

Neu Differentiation Factor-Beta (NFD-ß), a Potent Inhibitor of Angiogenesis and a Schwann-Cell Derived Factor Capable of Inducing Differentiation in Human Neuroblastoma Tumor Cells

03/19/2002

99-003

Glucose Sensitive Regulator of Insulin Transcription